Clinical Trial Update: Characterization of Rhythmicity Profiles of Bradykinin-mediated Angioedema Attacks Using a Tracking Smartphone Application.

View source ↗

Summary

A clinical trial evaluating rhythmicity profiles of bradykinin-mediated angioedema attacks using a smartphone tracking app has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bradykinin-mediated Angioedema

Snippet

Sponsor: University Hospital, Lille | Conditions: Bradykinin-mediated Angioedema | Status: WITHDRAWN